MIRA JEONG to Cell Line, Tumor
This is a "connection" page, showing publications MIRA JEONG has written about Cell Line, Tumor.
Connection Strength
0.012
-
DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia. Blood. 2016 08 18; 128(7):971-81.
Score: 0.012